Baxter International is selling its biopharma solutions business to private equity firms. The transaction is part of a broader trend in which life science firms are spinning out or selling operations in order to hone the focus of the remaining business on certain areas.
In a move that could position Walgreens to own one of the largest drug distributors to retail pharmacies and physicians, the retail drugstore giant is in talks with Amerisource Bergen, according to The Wall Street Journal.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Baxter International, a medical device company, and Matter, a health technology incubator, will work together to improve healthcare quality and value.
The original agreement between Walgreens and Rite Aid is no more. Rather, Walgreens will pay $5.175 billion to purchase 2,186 Rite Aid stores.
Walgreens alleges that Theranos misled the retailer about the state of its technology when the two companies inked a deal, the article noted. The lawsuit follows another complaint against the blood testing business filed by Partner Fund Management.
Akari Therapeutics just got a big boost with additional proceeds due to private placement.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.